Sigma Healthcare Limited
SIG
Pozycja w akcjach
#1047
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Cena akcji
$1.95
Kapitalizacja rynkowa
$22.39B
Zmiana (1 dzień)
-0.18%
Zmiana (1 rok)
-1.35%
Kraj
AU
Handel Sigma Healthcare Limited (SIG)
Kategoria
Healthcare
Przychody dla Sigma Healthcare Limited (SIG)
Przychody w Jun 2026 TTM: $7.64B
Według najnowszych raportów finansowych Sigma Healthcare Limited, obecny przychód firmy (TTM) wynosi $7.64B. W roku 2024 firma osiągnęła przychód w wysokości $2.18B spadek w porównaniu do przychodu z roku 2023, który wynosił $2.58B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Sigma Healthcare Limited od 2001 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $7.64B | 150.36% |
| 2025 | $3.05B | 39.95% |
| 2024 | $2.18B | -15.49% |
| 2023 | $2.58B | 5.96% |
| 2022 | $2.44B | -5.99% |
| 2021 | $2.59B | 19.30% |
| 2020 | $2.17B | -24.90% |
| 2019 | $2.89B | -12.38% |
| 2018 | $3.30B | -0.28% |
| 2017 | $3.31B | 35.12% |
| 2016 | $2.45B | 0.35% |
| 2015 | $2.44B | -6.25% |
| 2014 | $2.60B | -15.90% |
| 2013 | $3.10B | 1.20% |
| 2012 | $3.06B | 4.45% |
| 2011 | $2.93B | 27.32% |
| 2010 | $2.30B | 4.91% |
| 2009 | $2.19B | -18.21% |
| 2008 | $2.68B | 26.67% |
| 2007 | $2.12B | 27.55% |
| 2006 | $1.66B | 531.67% |
| 2004 | $262.65M | 32.71% |
| 2003 | $197.92M | 42.01% |
| 2002 | $139.37M | 98.14% |
| 2001 | $70.34M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $410.98B | 5,278.14% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,227.10% |
US
|
|
| - | - |
US
|
|
| $13.60B | 78.00% |
US
|
